Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Wilson

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 21, 2015
Variations in compliance to quality indicators by age for 41,871 breast cancer patients across Europe: a European Society of Breast Cancer Specialists database analysisMandy Kiderlen, Antonio Ponti, Mariano Tomatis, et al.
JAMA Psychiatry|September 1, 2018
Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis: A Randomized Clinical TrialSagnik Bhattacharyya, Robin Wilson, Elizabeth Appiah-Kusi, et al.
Plos One|March 25, 2016
Comparison of Dixon Sequences for Estimation of Percent Breast Fibroglandular TissueAraminta E W Ledger, Erica D Scurr, Julie Hughes, et al.
Translational Psychiatry|September 14, 2020
A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosisCathy Davies, Robin Wilson, Elizabeth Appiah-Kusi, et al.
Psychological Medicine|October 17, 2023
Increased hippocampal blood flow in people at clinical high risk for psychosis and effects of cannabidiolCathy Davies, Matthijs G Bossong, Daniel Martins, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 4, 2021
Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary reportCathy Davies, Elizabeth Appiah-Kusi, Robin Wilson, et al.
Schizophrenia Bulletin Open|August 15, 2024
Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis RiskCathy Davies, Matthijs G Bossong, Daniel Martins, et al.
Journal of Palliative Medicine|February 7, 2012
Improving access to palliative care through an innovative quality improvement initiative: an opportunity for pay-for-performanceRachelle E Bernacki, Danielle N Ko, Philip Higgins, et al.
Frontiers in Plant Science|August 14, 2024
The CIMMYT Australia ICARDA Germplasm Evaluation concept: a model for international cooperation and impactRichard M Trethowan, Julie M Nicol, Amit Singh, et al.
Immunometabolism|June 28, 2021
Inflammation Meets Metabolism: Roles for the Receptor for Advanced Glycation End Products Axis in Cardiovascular DiseaseLaura Senatus, Michael MacLean, Lakshmi Arivazhagan, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|April 21, 2015
Variations in compliance to quality indicators by age for 41,871 breast cancer patients across Europe: a European Society of Breast Cancer Specialists database analysisMandy Kiderlen, Antonio Ponti, Mariano Tomatis, et al.
JAMA Psychiatry|September 1, 2018
Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis: A Randomized Clinical TrialSagnik Bhattacharyya, Robin Wilson, Elizabeth Appiah-Kusi, et al.
Plos One|March 25, 2016
Comparison of Dixon Sequences for Estimation of Percent Breast Fibroglandular TissueAraminta E W Ledger, Erica D Scurr, Julie Hughes, et al.
Translational Psychiatry|September 14, 2020
A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosisCathy Davies, Robin Wilson, Elizabeth Appiah-Kusi, et al.
Psychological Medicine|October 17, 2023
Increased hippocampal blood flow in people at clinical high risk for psychosis and effects of cannabidiolCathy Davies, Matthijs G Bossong, Daniel Martins, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 4, 2021
Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary reportCathy Davies, Elizabeth Appiah-Kusi, Robin Wilson, et al.
Schizophrenia Bulletin Open|August 15, 2024
Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis RiskCathy Davies, Matthijs G Bossong, Daniel Martins, et al.
Journal of Palliative Medicine|February 7, 2012
Improving access to palliative care through an innovative quality improvement initiative: an opportunity for pay-for-performanceRachelle E Bernacki, Danielle N Ko, Philip Higgins, et al.
Frontiers in Plant Science|August 14, 2024
The CIMMYT Australia ICARDA Germplasm Evaluation concept: a model for international cooperation and impactRichard M Trethowan, Julie M Nicol, Amit Singh, et al.
Immunometabolism|June 28, 2021
Inflammation Meets Metabolism: Roles for the Receptor for Advanced Glycation End Products Axis in Cardiovascular DiseaseLaura Senatus, Michael MacLean, Lakshmi Arivazhagan, et al.
Pageof 4